Supplemental Figure 1 from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies
Stephen M. Ansell,Michael B. Maris,Alexander M. Lesokhin,Robert W. Chen,Ian W. Flinn,Ahmed Sawas, Mark D. Minden,Diego Villa, Mary-Elizabeth M. Percival, Anjali S. Advani, James M. Foran,Steven M. Horwitz,Matthew G. Mei,Jasmine Zain,Kerry J. Savage,Christiane Querfeld,Oleg E. Akilov,Lisa D.S. Johnson,Tina Catalano,Penka S. Petrova,Robert A. Uger,Eric L. Sievers,Anca Milea,Kathleen Roberge,Yaping Shou,Owen A. O'Connor crossref（2023）
AI 理解论文
溯源树
样例
